Literature DB >> 19265871

Kerriamycin B inhibits protein SUMOylation.

Isao Fukuda1, Akihiro Ito, Masakazu Uramoto, Hisato Saitoh, Hisashi Kawasaki, Hiroyuki Osada, Minoru Yoshida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19265871     DOI： 10.1038/ja.2009.10

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  22 in total

1.  An in vitro Förster resonance energy transfer-based high-throughput screening assay for inhibitors of protein-protein interactions in SUMOylation pathway.

Authors:  Yang Song; Jiayu Liao
Journal:  Assay Drug Dev Technol       Date:  2011-12-22       Impact factor: 1.738

2.  Inhibition of protein SUMOylation by natural quinones.

Authors:  Isao Fukuda; Mikako Hirohama; Akihiro Ito; Mohammad Tariq; Yasuhiro Igarashi; Hisato Saitoh; Minoru Yoshida
Journal:  J Antibiot (Tokyo)       Date:  2016-03-09       Impact factor: 2.649

Review 3.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

4.  SUMO-mimicking peptides inhibiting protein SUMOylation.

Authors:  Bo Zhao; Eric B Villhauer; Karan Bhuripanyo; Hiroaki Kiyokawa; Hermann Schindelin; Jun Yin
Journal:  Chembiochem       Date:  2014-11-20       Impact factor: 3.164

5.  Synthesis of 2',3',4'-trihydroxyflavone (2-D08), an inhibitor of protein sumoylation.

Authors:  Yeong Sang Kim; Samantha G L Keyser; John S Schneekloth
Journal:  Bioorg Med Chem Lett       Date:  2014-01-11       Impact factor: 2.823

6.  An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation.

Authors:  Yeong Sang Kim; Katelyn Nagy; Samantha Keyser; John S Schneekloth
Journal:  Chem Biol       Date:  2013-04-18

7.  Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.

Authors:  Xingyue He; Jessica Riceberg; Teresa Soucy; Erik Koenig; James Minissale; Melissa Gallery; Hugues Bernard; Xiaofeng Yang; Hua Liao; Claudia Rabino; Pooja Shah; Kristina Xega; Zhong-Hua Yan; Mike Sintchak; John Bradley; He Xu; Matt Duffey; Dylan England; Hirotake Mizutani; Zhigen Hu; Jianping Guo; Ryan Chau; Lawrence R Dick; James E Brownell; John Newcomb; Steve Langston; Eric S Lightcap; Neil Bence; Sai M Pulukuri
Journal:  Nat Chem Biol       Date:  2017-09-11       Impact factor: 15.040

Review 8.  Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.

Authors:  Marta Prieto; Alessandra Folci; Stéphane Martin
Journal:  Mol Psychiatry       Date:  2019-12-10       Impact factor: 15.992

Review 9.  SUMOylation in brain ischemia: Patterns, targets, and translational implications.

Authors:  Joshua D Bernstock; Wei Yang; Daniel G Ye; Yuntian Shen; Stefano Pluchino; Yang-Ja Lee; John M Hallenbeck; Wulf Paschen
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-17       Impact factor: 6.200

Review 10.  Current Status of SUMOylation Inhibitors.

Authors:  Christopher M Brackett; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2021       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.